Vivos Therapeutics Inc.

3.26
-0.21 (-6.05%)
At close: Mar 03, 2025, 3:59 PM
3.17
-2.76%
After-hours: Mar 03, 2025, 06:12 PM EST

Vivos Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 13.8M 16.02M 16.89M 13.07M 11.39M 3.79M
Cost of Revenue 5.53M 6M 4.28M 2.65M 2.74M 1.08M
Gross Profit 8.27M 10.02M 12.6M 10.41M 8.66M 2.71M
Operating Income -17.3M -25.03M -19.47M -8.71M -10.58M -8.34M
Interest Income n/a 89K 117K 79.61K 21.13K n/a
Pretax Income -13.58M -23.84M -20.29M -12.06M -10.75M -8.44M
Net Income -13.58M -22.66M -20.29M -8.82M -10.89M -8.54M
Selling & General & Admin 24.85M 34.38M 31.34M 18.4M 18.48M 10.44M
Research & Development 100K 200K n/a n/a n/a n/a
Other Expenses 621K 669K 733K 717.87K 751.23K 610.67K
Operating Expenses 25.57M 35.05M 32.08M 19.12M 19.23M 11.05M
Interest Expense n/a n/a 14K 96.68K 137.88K 102.97K
Selling & Marketing Expenses 2.47M 5.34M 5.55M 2.31M 2.31M 1.16M
Cost & Expenses 31.1M 41.05M 36.36M 21.78M 21.97M 12.13M
Income Tax n/a -1.19M 5K -3.23M 137.88K 102.97K
Shares Outstanding (Basic) 1.22M 920.48K 849.32K 728.38K 496.43K 461.93K
Shares Outstanding (Diluted) 1.22M 920.48K 849.32K 728.38K 496.43K 461.93K
EPS (Basic) -11.14 -24.62 -23.89 -12.11 -21.94 -18.49
EPS (Diluted) -11.14 -24.62 -23.89 -12.11 -21.94 -18.49
EBITDA -16.68M -24.36M -19.54M -11.24M -9.87M -7.73M
Depreciation & Amortization 621K 669K 733K 717.87K 751.23K 610.67K